Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TIMM10 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.007 |
mRNA | ARHGAP9 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.007 |
mRNA | RASD2 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.007 |
mRNA | POC1A | CTRPv2 | pan-cancer | AAC | -0.097 | 0.007 |
mRNA | FAM47E | CTRPv2 | pan-cancer | AAC | 0.093 | 0.007 |
mRNA | PROSC | CTRPv2 | pan-cancer | AAC | 0.092 | 0.007 |
mRNA | NNMT | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
mRNA | GPS2 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.007 |
mRNA | ASCC1 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.007 |
mRNA | AGPAT5 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.007 |